M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical TechnologyMerck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences. M&A / DealsRead full story Post navigation Previous: Alzheimer’s biotech Korsana to go public via reverse mergerNext: Threat of Trump’s pharma tariffs looms again Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
